A machine learning tool to predict mortality risk among patients with metastatic cancer in outpatient oncology care.

Authors

Brandon Butler

Brandon Butler

McKesson Corporation, The Woodlands, TX

Brandon Butler , Nadaa Tayiab , Serra Phu , Susan Nga Hoang , Brian Turnwald , Jody S. Garey , Bo He , John Russell Hoverman

Organizations

McKesson Corporation, The Woodlands, TX, McKesson, Scottsdale, AZ, GE Healthcare, Wauwatosa, WI, McKesson Specialty Health, The Woodlands, TX, US Oncology, Houston, TX, Texas Oncology/The US Oncology Network, Dallas, TX

Research Funding

Other
McKesson / US Oncology Network (USON)

Background: End-of-life management is a well-known challenging aspect of cancer care. In particular, timely hospice enrollment is a leading quality metric in the Oncology Care Model that has substantial room for improvement. An automated algorithmic tool that can incorporate the wealth of available EHR data and rapidly identify patients with a high risk of imminent mortality could be a valuable asset to supplement important clinical decisions and improve timely hospice care. Methods: A retrospective study cohort was formed using patients with metastatic cancer from US Oncology Network (USON) practices participating in the Oncology Care Model (OCM) between January 1, 2017 and June 30, 2019. Patients were required to have at least one record for lab values and vital signs in the EHR database. Patients were excluded from the study cohort if they were not enrolled in the OCM program or did not have a diagnosis for metastatic cancer. The patients satisfying the selection criterion were used to train and optimize the model. The training dataset was also used for internal validation and hyperparameter tuning until the final model was produced. As external validation, the final model was independently tested on 3 separate holdout datasets including OCM patients between July 1, 2019 and March 31, 2020. To avoid bias, all holdout datasets used for validation were excluded from the model. Results: A multivariable model to predict 90-day mortality was developed using a retrospective dataset derived from EHR data and Medicare claims data. A logistic regression algorithm using L1 (lasso) regularization yielded the best performance compared to other model candidates. The performance on the training cohort was given by a cross-validated AUC score of 0.85 (95% CI, 0.84 to 0.86). Further, external validation conducted using 3 independent holdout datasets demonstrated impressive generalizability marked by stable performance scores across multiple time periods (AUC between 0.84 and 0.85). Conclusions: This study builds upon previous work and further establishes the utility of machine learning to predict risk of imminent mortality for advanced cancer patients using available EHR data. A data-driven tool that estimates the probability of 90-day mortality could be leveraged as a powerful supplementary aid to clinicians managing end-of-life care at oncology practices.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Care Delivery and Regulatory Policy

Track

Care Delivery and Quality Care

Sub Track

Clinical Informatics/Advanced Algorithms/Machine Learning

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 1560)

DOI

10.1200/JCO.2021.39.15_suppl.1560

Abstract #

1560

Poster Bd #

Online Only

Abstract Disclosures

Similar Abstracts

First Author: Chris Manz

First Author: Tom William Andrew

First Author: Edward Christopher Dee